期刊文献+

糖尿病高血压对心血管病变的影响及其干预治疗 被引量:5

Effects of diabetes,hypertension and intervene treat on cardiovascular disease
下载PDF
导出
摘要 目的 探讨糖尿病 (DM)和 (或 )高血压 (EH)对心血管病变的影响 ,以及降压和控制血糖的意义。方法 选择 2型 DM患者 16 8例 ,EH患者 112例 ,DM+EH患者 12 0例 ,正常对照组 110例 ,4组均测定空腹及餐后 2小时血糖和 C肽、糖化血红蛋白、血脂谱。 EH患者采用非洛地平为主的治疗方案 ,控制血压达目标值。随诊3年观察心血管病变发生情况。结果  DM+EH组、DM组、EH组心血管并发症患病率依次为 2 2 .5 %、15 .5 %、11.2 % ,治疗血压达目标值后 ,DM+EH组、EH组心血管并发症总发生率为 2 .6 %。结论 对 DM+EH患者 ,在良好控制血糖的同时强化血压达标 ,可减缓心血管并发症发生。 Objective To investigate the influence of blood pressure and glucose metabolism on cardiovascular events and estimate the meaning of controled blood pressure and glucose in type 2 diabetic and/or hypertension patients.Methods 168 cases with T2DM,112 cases with hypertension,120 cases with T2DM and hypertension were selected randomly.110 healthy persons served as control.The level of serum glucose,C-peptide,lipids,GHbA1c were tested.Treated program using felodipine added other drugs applied in 232 patients with hypertension and blood pressure controled to target value.Onset of cardiovascular disease was observed for three-year follow-up.Results Prevalence of cardiovascular disease in DM with hypertension group,DM group,hypertension group were 22.5%,15.5%,11.2%.Prevalence of cardiovascular disease in DM with hypertension group,hypertension group were 2.6% when blood pressure controled to target value in the groups.Conclusion To strengthen blood pressure controled to target value,the same controled blood glucose better may cause the more beneficial in DM with hypertension patients.
出处 《山东医药》 CAS 北大核心 2004年第19期12-13,共2页 Shandong Medical Journal
基金 济宁市科技局资助课题 ( No.2 0 0 1YW-2 5 )
关键词 糖尿病 高血压 心血管病变 干预治疗 Diabetes mellitus Hypertension Cardiovascular disease Intervene treat
  • 相关文献

参考文献2

  • 1National Cholesterol Education Program (NCEP).Detection,evaluation and treatment of high blood cholesterol in adult treatment panel.JAMA,2001,285:2486~2497.
  • 2Venkat NK,Gregg E,Engelgau M,et al.Translation research for chronic disease,the case of diabetes.Diabetes Care,2000,23:1974~1978.

同被引文献23

  • 1谢晓敏,刘惠莉,周海燕,于丽萍,张丽,李仁达,李玲,牛旭东,史静,侯庆宁,曾斌,邹晓燕.2型糖尿病患者大血管病变相关因素分析[J].宁夏医学杂志,2006,28(1):20-22. 被引量:7
  • 2于汇民,刘国仗.高血压与糖尿病共患与心血管疾病的关系[J].中国分子心脏病学杂志,2004,4(1):52-55. 被引量:11
  • 3于世鹏,班博,孙琳,孙海玲,张梅,李萍.二级预防对糖尿病高血压患者发生大血管并发症的影响:3年510例随访观察[J].中国临床康复,2006,10(24):4-6. 被引量:11
  • 4Kimura F,Hasegawa G,Obayashi H,et al.Serum extraeellular superoxide dismutase in patients with type 2 diabetes:relationship to the development of micro-and macrovascular complications[J].Diabetes Care,2003,26(4):1246-1250.
  • 5Fujita M, Asanuma H, Kim J, el al. Impaired glucose tolerance: apossible contributor to left ventricular hypertrophy and diastolic dysfunction[J]. Int J Cardio, 2007, 118 (1): 76-80.
  • 6Brohall G, Oden A, Fagerberg B. Carotid artery, intima-madia thickness in patientswith type 2 diabetesmellitus and impaired glucose to lerance: a systematic review [J ]. Diabetic Med, 2006, 23 (6) : 609-616.
  • 7Boulton A J, Malik gA. Neuropathy of impaired glucose tolerance and its measurement[J]. Diabetes Care,2010, 330): 207-209.
  • 8Loll I,Hodr 6uez-calvo tarroso L, et aJ. Feroxlsome prolifertor-activated receptor (PPAE) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome[J].Curr Mol Pharmacol,2009, 2(1): 46-55.
  • 9Califf EM, Boolell M, Haffnerand cardiovascular disease in patients rationale and design of the Nateglinide Tolerance Outcomes Eesearch (NAVlGATOg) 625 632 8M, et al. Prevention of diabetes with impaired glucose Lolerance: and Valsartan in Impared Glucose Trial[J].Am Heart J,2008,156(4),.
  • 10Li YQ, Zhou FC, Oao F, et al. Comparative evaluation of quercetin,isoquercetin and turin as mhibitors of alpha-glucosidase[J]. J Agric Food Chem,2009, 57(24):1461-11468.

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部